Search

everythinglearnresearchcommunity

for

Search:↓

The COVID-19 pandemic led to fewer dermatology patients, more stress-related skin conditions during the crisis, and a rise in contact dermatitis after, with ongoing concerns for public health and treatment delays.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Sex hormones affect brain injury differently in males and females.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Combined finasteride and anastrozole therapy effectively treats BPH, influenced by hormone imbalances and genetics.

WNT10A mutations often cause ectodermal dysplasias, with males showing more tooth issues than females.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Lower SHBG levels may increase the risk of PCOS.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Pregnancy causes skin changes like darkening, hair thickening, nail changes, and increased risk of skin growths, most of which usually resolve after birth.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

SHBG may be a useful early indicator and treatment target for PCOS.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Hormones and genes affect hair growth and male baldness.

Testosterone makes the connections in the uterus lining simpler and lowers certain protein levels, which might lead to infertility.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.